BG100525A - Heteroatomic benzocyclopantane oxazolidinons having antibactericidal activity - Google Patents
Heteroatomic benzocyclopantane oxazolidinons having antibactericidal activityInfo
- Publication number
- BG100525A BG100525A BG100525A BG10052596A BG100525A BG 100525 A BG100525 A BG 100525A BG 100525 A BG100525 A BG 100525A BG 10052596 A BG10052596 A BG 10052596A BG 100525 A BG100525 A BG 100525A
- Authority
- BG
- Bulgaria
- Prior art keywords
- oxazolidinons
- benzocyclopantane
- heteroatomic
- formula
- antibactericidal
- Prior art date
Links
- 230000000922 anti-bactericidal effect Effects 0.000 title 1
- -1 azido, hydroxy Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19514769 | 1995-04-21 | ||
DE19544106A DE19544106A1 (de) | 1995-04-21 | 1995-11-27 | Heteroatomhaltige Benzocyclopentanoxazolidinone |
Publications (1)
Publication Number | Publication Date |
---|---|
BG100525A true BG100525A (en) | 1997-03-31 |
Family
ID=26014539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG100525A BG100525A (en) | 1995-04-21 | 1996-04-19 | Heteroatomic benzocyclopantane oxazolidinons having antibactericidal activity |
Country Status (21)
Country | Link |
---|---|
US (1) | US6069160A (ja) |
EP (1) | EP0738726B1 (ja) |
JP (1) | JP3967401B2 (ja) |
CN (1) | CN1138582A (ja) |
AT (1) | ATE206120T1 (ja) |
AU (1) | AU705071B2 (ja) |
BG (1) | BG100525A (ja) |
CA (1) | CA2174473A1 (ja) |
CZ (1) | CZ114296A3 (ja) |
EE (1) | EE9600043A (ja) |
ES (1) | ES2164182T3 (ja) |
HR (1) | HRP960159A2 (ja) |
HU (1) | HUP9601001A3 (ja) |
IL (1) | IL117954A0 (ja) |
MA (1) | MA23845A1 (ja) |
MX (1) | MX9601399A (ja) |
NO (1) | NO305909B1 (ja) |
NZ (1) | NZ286400A (ja) |
SG (1) | SG52774A1 (ja) |
SK (1) | SK50096A3 (ja) |
TR (1) | TR199600319A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114075439A (zh) * | 2021-12-07 | 2022-02-22 | 西安瑞联新材料股份有限公司 | 一种苯并戊烷类液晶化合物及其组合物 |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9601666D0 (en) * | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
DE19604223A1 (de) | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
GB9609919D0 (en) * | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
GB9717807D0 (en) * | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
US6617453B1 (en) | 1997-10-24 | 2003-09-09 | Clariant Finance (Bvi) Limited | Triphendioxazine compounds |
DE19747175A1 (de) | 1997-10-24 | 1999-04-29 | Clariant Int Ltd | Chlorhaltige Triphendioxazin-Verbindungen |
CA2309319A1 (en) | 1997-11-10 | 1999-05-20 | Bristol-Myers Squibb Company | Benzothiazole protein tyrosine kinase inhibitors |
GB9725244D0 (en) | 1997-11-29 | 1998-01-28 | Zeneca Ltd | Chemical compounds |
US6562844B2 (en) | 1998-01-23 | 2003-05-13 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
JP2002501059A (ja) | 1998-01-23 | 2002-01-15 | ファルマシア・アンド・アップジョン・カンパニー | オキサゾリジノンの組合せライブラリー、組成物および調製方法 |
US7002020B1 (en) | 1998-01-23 | 2006-02-21 | Pharmacia & Upjohn Company | Oxazolidinone combinatorial libraries, compositions and methods of preparation |
WO2000029409A1 (de) * | 1998-11-17 | 2000-05-25 | Bayer Aktiengesellschaft | Neue heterocyclyl-substituierte oxazolidon-derivate |
DE19905278A1 (de) * | 1999-02-09 | 2000-08-10 | Bayer Ag | Oxazolidinone und ihre Verwendung als antibakterielle Mittel |
DE19913401A1 (de) | 1999-03-25 | 2000-09-28 | Clariant Gmbh | Verfahren zur Herstellung von Dioxazin-Verbindungen |
NZ516853A (en) | 1999-07-28 | 2003-11-28 | Upjohn Co | Oxazolidinones and their use as anti-infectives |
GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
US6518285B2 (en) | 1999-12-21 | 2003-02-11 | Ortho Mcneil Pharmaceutical, Inc. | Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials |
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
PE20011124A1 (es) * | 2000-03-31 | 2001-10-28 | Upjohn Co | Nuevos agentes antibacterianos de benzosultam oxazolidinona |
GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
WO2002032857A1 (en) * | 2000-10-17 | 2002-04-25 | Pharmacia & Upjohn Company | Methods of producing oxazolidinone compounds |
DK1341769T3 (da) * | 2000-12-15 | 2008-01-28 | Vertex Pharma | Bakterielle gyrase-inhibitorer og anvendelser deraf |
EP1385834B1 (en) * | 2001-04-17 | 2005-09-14 | Merck & Co., Inc. | Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof |
EP1379246B1 (en) | 2001-04-18 | 2008-10-08 | Euro-Celtique S.A. | Nociceptin analogs |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
JP2005511688A (ja) * | 2001-11-29 | 2005-04-28 | メルク アンド カンパニー インコーポレーテッド | シクロプロピル含有オキサゾリジノン抗生物質及びその誘導体 |
AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
US7141588B2 (en) * | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
US20030216330A1 (en) * | 2002-03-29 | 2003-11-20 | Pharmacia & Upjohn | Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
BR0313400A (pt) * | 2002-08-12 | 2005-07-12 | Pharmacia & Upjohn Co Llc | N-aril-2-oxazolidinonas e seus derivados |
AU2002339721A1 (en) * | 2002-09-20 | 2004-04-08 | Lupin Limited | Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents |
US7141570B2 (en) * | 2002-11-21 | 2006-11-28 | Pharmacia & Upjohn Company | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
DE10300111A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
US7569591B2 (en) | 2003-01-31 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US8193352B2 (en) | 2003-01-31 | 2012-06-05 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US7618974B2 (en) | 2003-01-31 | 2009-11-17 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
US7582641B2 (en) | 2003-01-31 | 2009-09-01 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US8404852B2 (en) | 2003-01-31 | 2013-03-26 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
EP1594494A1 (en) * | 2003-02-07 | 2005-11-16 | Warner-Lambert Company LLC | Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents |
WO2004069832A2 (en) * | 2003-02-07 | 2004-08-19 | Warner-Lambert Company Llc | Antibacterial agents |
US7012088B2 (en) | 2003-02-24 | 2006-03-14 | Pharmacia & Upjohn Company | Indolone oxazolidinones and derivatives thereof |
US20040204463A1 (en) * | 2003-04-01 | 2004-10-14 | Harris Christina Renee | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
US20070293493A1 (en) * | 2003-07-02 | 2007-12-20 | Milton Hammond | Oxazolidinone antibiotics and derivatives thereof |
KR20060113625A (ko) * | 2003-07-02 | 2006-11-02 | 머크 앤드 캄파니 인코포레이티드 | 시클로프로필기 치환된 옥사졸리디논 항생제 및 그의유도체 |
AU2004256084B2 (en) * | 2003-07-02 | 2007-10-18 | Kyorin Pharmaceutical Co., Ltd. | Oxazolidinone antibiotics and derivatives thereof |
JP2007521283A (ja) * | 2003-07-02 | 2007-08-02 | メルク アンド カンパニー インコーポレーテッド | シクロプロピル基で置換されたオキサゾリジノン系抗生物質およびその誘導体 |
US7304050B2 (en) * | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
WO2005082897A1 (en) * | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone antibacterial agents |
WO2005082900A2 (en) * | 2004-01-28 | 2005-09-09 | Pharmacia & Upjohn Company Llc | Oxazolidinone amidoximes as antibacterial agents |
AU2005270951A1 (en) * | 2004-08-06 | 2006-02-16 | Pharmacia & Upjohn Company Llc | Oxazolidinones containing oxindoles as antibacterial agents |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
EP1685841A1 (en) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
WO2006106426A1 (en) * | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | An oxindole oxazolidinone as antibacterial agent |
DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
NZ567092A (en) | 2005-10-04 | 2011-05-27 | Bayer Schering Pharma Ag | Novel polymorphous form and the amorphous form of 5-chloro-N-({ (5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
DE102005048824A1 (de) * | 2005-10-10 | 2007-04-12 | Bayer Healthcare Ag | Behandlung und Prophylaxe von Mikroangiopathien |
DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
TWI546298B (zh) | 2011-01-14 | 2016-08-21 | 維泰克斯製藥公司 | 旋轉酶及拓樸異構酶iv抑制劑 |
BR112013017985B1 (pt) | 2011-01-14 | 2021-06-29 | Spero Therapeutics Inc. | Formas sólidas de inibidor de girase (r)-1-etil-3-[6-flúor-5-[2-(1-hidróxi-1-metil-etil)pirimidin- 5-il]-7-(tetra-hidrofuran-2-il)-1h-benzimidazol-2-il]ureia, seu sal de ácido clorídrico, método de preparação das mesmas e composição farmacêutica que os compreende |
CA2824519C (en) | 2011-01-14 | 2020-06-16 | Vertex Pharmaceuticals Incorporated | Process of making gyrase and topoisomerase inhibitors |
BR112013017977A2 (pt) | 2011-01-14 | 2019-09-24 | Vertex Pharma | formas sólidas de inibidor de girase (r) 1-etil-3-[5-[2-{1-hidroxi-1-metil-etil}pirimidin-5-il]-7-(tetrai-drofuran-2-il)-1h-benzimidazol-2-il]ureia |
CN103702994B (zh) | 2011-06-20 | 2016-03-23 | 沃泰克斯药物股份有限公司 | 旋转酶和拓扑异构酶抑制剂的磷酸酯 |
WO2014015105A1 (en) | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Solid forms of (r)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1h-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
WO2014014845A1 (en) | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases |
US9814235B2 (en) | 2013-01-30 | 2017-11-14 | Sumitomo Chemical Company, Limited | Method for controlling arthropod pest |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4705799A (en) * | 1983-06-07 | 1987-11-10 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents |
DE3723797A1 (de) * | 1987-07-18 | 1989-01-26 | Merck Patent Gmbh | Oxazolidinone |
US4801600A (en) * | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
US4965268A (en) * | 1987-10-09 | 1990-10-23 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
US4921869A (en) * | 1987-10-09 | 1990-05-01 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
CA1320730C (en) * | 1987-10-16 | 1993-07-27 | The Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
US5254577A (en) * | 1988-07-29 | 1993-10-19 | The Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
WO1990002744A1 (en) * | 1988-09-15 | 1990-03-22 | The Upjohn Company | In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones |
JP2669579B2 (ja) * | 1991-10-23 | 1997-10-29 | エーザイ株式会社 | オキサゾリドン誘導体 |
DE19514313A1 (de) * | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
-
1996
- 1996-04-04 HR HR19544106.0A patent/HRP960159A2/hr not_active Application Discontinuation
- 1996-04-09 EP EP96105539A patent/EP0738726B1/de not_active Expired - Lifetime
- 1996-04-09 AT AT96105539T patent/ATE206120T1/de not_active IP Right Cessation
- 1996-04-09 ES ES96105539T patent/ES2164182T3/es not_active Expired - Lifetime
- 1996-04-12 US US08/631,516 patent/US6069160A/en not_active Expired - Fee Related
- 1996-04-15 MX MX9601399A patent/MX9601399A/es unknown
- 1996-04-16 JP JP11711796A patent/JP3967401B2/ja not_active Expired - Fee Related
- 1996-04-17 AU AU50735/96A patent/AU705071B2/en not_active Ceased
- 1996-04-17 TR TR96/00319A patent/TR199600319A2/xx unknown
- 1996-04-17 HU HU9601001A patent/HUP9601001A3/hu unknown
- 1996-04-18 NZ NZ286400A patent/NZ286400A/en unknown
- 1996-04-18 CA CA002174473A patent/CA2174473A1/en not_active Abandoned
- 1996-04-18 IL IL11795496A patent/IL117954A0/xx unknown
- 1996-04-19 CZ CZ961142A patent/CZ114296A3/cs unknown
- 1996-04-19 NO NO961559A patent/NO305909B1/no unknown
- 1996-04-19 MA MA24205A patent/MA23845A1/fr unknown
- 1996-04-19 SG SG1996009312A patent/SG52774A1/en unknown
- 1996-04-19 CN CN96106152A patent/CN1138582A/zh active Pending
- 1996-04-19 EE EE9600043A patent/EE9600043A/xx unknown
- 1996-04-19 BG BG100525A patent/BG100525A/xx unknown
- 1996-04-19 SK SK500-96A patent/SK50096A3/sk unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114075439A (zh) * | 2021-12-07 | 2022-02-22 | 西安瑞联新材料股份有限公司 | 一种苯并戊烷类液晶化合物及其组合物 |
CN114075439B (zh) * | 2021-12-07 | 2023-07-28 | 西安瑞联新材料股份有限公司 | 一种苯并戊烷类液晶化合物及其组合物 |
Also Published As
Publication number | Publication date |
---|---|
MX9601399A (es) | 1997-04-30 |
US6069160A (en) | 2000-05-30 |
CZ114296A3 (en) | 1997-07-16 |
JP3967401B2 (ja) | 2007-08-29 |
SG52774A1 (en) | 1998-09-28 |
EP0738726A1 (de) | 1996-10-23 |
EP0738726B1 (de) | 2001-09-26 |
ES2164182T3 (es) | 2002-02-16 |
HRP960159A2 (en) | 1997-08-31 |
CA2174473A1 (en) | 1996-10-22 |
HU9601001D0 (en) | 1996-06-28 |
IL117954A0 (en) | 1996-08-04 |
NZ286400A (en) | 1998-04-27 |
EE9600043A (et) | 1996-12-16 |
HUP9601001A3 (en) | 1999-03-01 |
TR199600319A2 (tr) | 1996-11-21 |
NO305909B1 (no) | 1999-08-16 |
CN1138582A (zh) | 1996-12-25 |
AU705071B2 (en) | 1999-05-13 |
JPH08301869A (ja) | 1996-11-19 |
ATE206120T1 (de) | 2001-10-15 |
SK50096A3 (en) | 1997-05-07 |
AU5073596A (en) | 1996-10-31 |
MA23845A1 (fr) | 1996-12-31 |
NO961559L (no) | 1996-10-22 |
NO961559D0 (no) | 1996-04-19 |
HUP9601001A2 (hu) | 1998-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG100525A (en) | Heteroatomic benzocyclopantane oxazolidinons having antibactericidal activity | |
AU3367995A (en) | New multimerizing agents | |
BG103518A (en) | 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives | |
BG103485A (en) | Ketobanzamides as calpain inhibitors | |
BG101110A (en) | Substituted pyrimidine compounds and their application | |
BG102425A (en) | (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors | |
IL117848A0 (en) | Novel compounds a process for their production and pharmacetical compositions containing same | |
TW263499B (ja) | ||
ATE255589T1 (de) | Kristallin form i von clarithromycin | |
UA66750C2 (en) | Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors | |
IL112539A0 (en) | Pyrimidine derivatives and their preparation | |
AU3631197A (en) | N-benzylpiperidine and tetrahydropyridine derivatives | |
BG105009A (en) | Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline | |
MX9503529A (es) | Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen. | |
BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
MY106202A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof. | |
MX9700257A (es) | Nuevas estreptograminas y procedimiento de preparacion de estreptograminas por mutasintesis. | |
AU2838497A (en) | Process for the preparation of substituted aryllactic acid- containing cyclodepsipeptides having 24 ring atoms | |
JO2252B1 (en) | Method for preparing pyridine derivatives | |
ES8707538A1 (es) | Procedimiento para preparar 5h,11h-pirrolo (2,1c)-(1,4)ben- zoxazepinas sustituidas en posicion 11 | |
YU12000A (sh) | Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova | |
MX9801938A (es) | Derivados de 3-beta-aminoazabiciclo-octano-naftamida o 3-beta-aminoazabiciclo-nonano-naftamida como agentes antipsicoticos. | |
MX9500228A (es) | N-oxidos de 4-arilpiperazinas y 4-arilpiperidinas. | |
ZA200005110B (en) | Process for preparing intermediates. | |
EG20562A (en) | Process for preparing glutaramide derivatives |